Drug repositioning and its aspects in clinical diabetology

被引:0
作者
Pokoly, Bence [1 ,2 ]
Somogyi, Aniko [3 ]
机构
[1] Orszag Reumatol Fizioterap Int, Orszag Mozgasszerv Int, Budapest, Hungary
[2] Szent Margit Korhaz, Budapest, Hungary
[3] Semmelweis Egyet, Altalan Orvostudomany Kar, Belgyogyaszat Hematol Klinika, Budapest, Hungary
关键词
drug repositioning; diabetes mellitus; treatment; CARDIOVASCULAR OUTCOMES; THALIDOMIDE; LIRAGLUTIDE;
D O I
10.1556/650.2024.33177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Drug repositioning is a special and increasingly utilized way of drug development. As a result of the procedure, drugs and active ingredients that are already on the market for the treatment of certain diseases or are in various phases of development are being successfully used with new indications, some of which are sometimes completely different from the original ones. In the first half of our review, we give a brief overview of this process, outline its various advantages and potential pitfalls. After the general introductory part, we will examine the more successful areas of application of the drugs that were previously marketed as antidiabetics, and then we will mention some preparations that can now also be used in the treatment of diabetes mellitus, due to their significant blood sugar lowering properties that have been recognized in the meantime. Orv Hetil. 2024; 165(49): 1919-1926.
引用
收藏
页码:1919 / 1926
页数:8
相关论文
共 50 条
[21]   In Silico Drug Repositioning for Chagas Disease [J].
Bellera, Carolina L. ;
Alberca, Lucas N. ;
Sbaraglini, Maria L. ;
Talevi, Alan .
CURRENT MEDICINAL CHEMISTRY, 2020, 27 (05) :662-675
[22]   Drug Repositioning by Bipartite Local Models [J].
Nguyen, Phuong H. ;
Le, Duc-Hau .
PROCEEDINGS OF 2018 5TH NAFOSTED CONFERENCE ON INFORMATION AND COMPUTER SCIENCE (NICS 2018), 2018, :30-34
[23]   A Review of Computational Drug Repositioning Approaches [J].
Huang, Guohua ;
Li, Jincheng ;
Wang, Peng ;
Li, Weibiao .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2017, 20 (10) :831-838
[24]   Drug repositioning for COVID-19 [J].
Benavides-Cordoba, Vicente .
COLOMBIA MEDICA, 2020, 51 (02)
[25]   Topological network measures for drug repositioning [J].
Badkas, Apurva ;
De Landtsheer, Sebastien ;
Sauter, Thomas .
BRIEFINGS IN BIOINFORMATICS, 2021, 22 (04)
[26]   Computational Drug Repositioning for Cancer Therapeutics [J].
Jiao, Mingkun ;
Liu, Gang ;
Xue, Yu ;
Ding, Chunyong .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (08) :767-775
[27]   Changing Trends in Computational Drug Repositioning [J].
Yella, Jaswanth K. ;
Yaddanapudi, Suryanarayana ;
Wang, Yunguan ;
Jegga, Anil G. .
PHARMACEUTICALS, 2018, 11 (02)
[28]   Transcriptome-Guided Drug Repositioning [J].
Arakelyan, Arsen ;
Nersisyan, Lilit ;
Nikoghosyan, Maria ;
Hakobyan, Siras ;
Simonyan, Arman ;
Hopp, Lydia ;
Loeffler-Wirth, Henry ;
Binder, Hans .
PHARMACEUTICS, 2019, 11 (12)
[29]   The Immunogenetics of Psoriasis and Implications for Drug Repositioning [J].
Xu, Xuan ;
Zhang, Hong-Yu .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
[30]   Automatic collaborative learning for drug repositioning [J].
Wang, Yi ;
Meng, Yajie ;
Zhou, Chang ;
Tanga, Xianfang ;
Zeng, Pan ;
Panc, Chu ;
Zhu, Qiang ;
Zhang, Bengong ;
Xu, Junlin .
ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE, 2025, 139